REVIVA PHARMACEUTICALS HOLDINGS, INC. has filed 404 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |
| SC 13G | 2026-05-14 | Beneficial Ownership Report (Passive) |
| 8-K | 2026-05-13 | Notice of Delisting or Transfer; Other Events |
| 8-K | 2026-05-13 | Results of Operations and Financial Condition; Regulation FD Disclosure |
| 10-Q | 2026-05-13 | Quarterly Report |
| 8-K | 2026-04-15 | Regulation FD Disclosure; Other Events |
| 10-K | 2026-03-30 | Annual Report |
| 8-K | 2026-03-30 | Results of Operations and Financial Condition; Regulation FD Disclosure |
| SCHEDULE 13G | 2026-03-30 | SCHEDULE 13G |
| S-8 | 2026-03-30 | Employee Benefit Plan Registration |